期刊文献+

携精氨酸-甘氨酸-天冬氨酸肽序列靶向超声微泡结合对比超声评价肿瘤新生血管 被引量:4

Evaluation of tumor angiogenesis using microbubbles conjugated with RGD peptides and contrast enhanced ultrasound
原文传递
导出
摘要 目的 探讨携精氨酸-甘氨酸-天冬氨酸(RGD)肽序列靶向超声微泡结合对比超声评价肿瘤新生血管的可行性.方法 应用声振法制备普通脂质微泡(MB),通过共价偶联的方法,将RGD肽序列连接在MB外壳,制备成靶向超声微泡(MBRGD).6只接种人肝癌HepG2细胞14 d的裸鼠(模型组)和6只未接种HepG2细胞的正常裸鼠(对照组),经尾静脉弹丸式注射等量MB和MBRGD,两次注射间隔30 min.注射10 min后,分别行肿瘤和骨骼肌的对比超声检查,测量肿瘤和骨骼肌的第1帧对比超声图像的声强度(VI),并对肿瘤组织和骨骼肌组织进行抗αvβ3-整合免疫组化检测.结果 模型组注射MBRGD和MB后,肿瘤第1帧对比超声图像分别显示显著及轻度的超声显影,VI值分别为17.03±3.58和5.33±1.71,注射MBRGD后的VI值是注射MB的3.18倍(P<0.05).对照组注射MBRGD和MB后,骨骼肌第1帧对比超声图像均无明显超声显影,VI值分别为3.10±0.48和2.90±0.29,两者差异无统计学意义(P>0.05).免疫组化检测显示,αvβ3-整合素在肿瘤新生血管内皮高度表达,而骨骼肌组织血管内皮却未见明显表达.结论 应用MBRGD行对比超声检查可有效评价肿瘤的新生血管,将有助于肿瘤性质的早期判断. Objective To assess the feasibility of usage of microbubbles conjugated with RGD peptides and contrast enhanced ultrasound (CEU) in detection of tumor angiogenesis. Methods Lipid microbubbles (MB) were prepared, and the RGD peptides were covalently conjugated to the lipid shell of MB (MBRGD). Six nude mice with tumor created by dorsal inoculation of HepG2 tumor cells were used as the test group. Six nude mice without tumor were served as the control group. 10 minutes after bolus injection of MB and MBRGD randomly (30 min interval) via a tail vein catheter, CEU was performed on the tumors of the test group and the thigh skeletal muscles of control group. The video intensity (VI) of tumors and the skeletal muscles were measured. The tumors and the skeletal muscles were harvested for immunohistochemical examination. Results Only a slight contrast enhancement of the tumor was seen with MB, and the VI was 5.33 ± 1.71. While a remarkable enhancement of the tumor was observed after injection of MBRGD. The VI was up to 17.03 ± 3.58, 3.18 folds higher as compared with that obtained by injection of MB (P 〈 0. 05). As expected, there were no obvious contrast enhancement of the skeletal muscles with both MBRGD and MB. There was a high expression of αvβ3-integrin in tumor neovascular endothelium, however, no apparent expression of αvβ3-integrin was observed in the skeletal muscle vascular endothelium. Conclusion CEU with MBRGD can be used to effectively evaluate the angiogenesis of tumors,and it may greatly contribute to the early judgement of the nature of tumor.
出处 《中华肿瘤杂志》 CAS CSCD 北大核心 2010年第9期655-658,共4页 Chinese Journal of Oncology
基金 国家“863”计划(2006AA022478) 广东省科技计划项目(2008J-C131)
关键词 靶向超声微泡 对比超声 αvβ3-整合素 新生血管 Targeted microbubbles Contrast enhanced ultrasound αvβ3-integrin Angiogenesis
  • 相关文献

参考文献16

  • 1Xie J,Shen Z,Li KC,et al,Tumor angiogenie endothelial cell targeting by a novel integrin-targeted nanoparticle.Int J Nanomedicine,2007,2:479-485.
  • 2Kumar CC.Integrin alpha v beta 3 as a therapeutic target for blocking tumor-induced angiogenesis.Curr Drug Target,2003,4:123-131.
  • 3Haubner R,Webster HJ,Weber WA,et al.Noninvasive imaging of αvβ3 integrin expression using 18F-labeled RGD-containing glycopeptide and positron emission tomography.Cancer Res,glycopeptide and positron emission tomography Cancer Res,2001,61:1781-1785.
  • 4Su ZF,Liu G,Gupta S,et al.In vitro and in vivo evaluation of a Technetium-99m-labeled cyclic RGD peptide as a specific marker of αvβ3 integrin for tumor imaging.Bioconjug Chem,2002,13:561-570.
  • 5Beer AJ,Schwaiger M.Imaging of integrin alphavbeta3 expression.Cancer Metastasis Rev,2008,27:631-644.
  • 6Sancey L,Ardisson V,Riou LM,et al.In vivo imaging of tumour angiogenesis in mice with the αvβ3 integrin-targeted tracer 95mTc-RAFT-RGD.Eur J Nucl Med Mol Imaging,2007,34:2037-2047.
  • 7李艳萍,徐惠绵,张斌.微血管计数与乳腺癌临床病理因素及预后的关系[J].中华肿瘤杂志,2000,22(6):498-499. 被引量:13
  • 8赵仲生,茹国庆,马杰.IGF-Ⅱ和HGF mRNA表达与胃癌微血管密度的关系[J].中华肿瘤杂志,2004,26(11):673-677. 被引量:27
  • 9李捷,宋三泰,江泽飞,刘晓晴,颜玲娣.血管内皮生长因子及微血管密度在乳腺癌中的表达及意义[J].中华肿瘤杂志,2003,25(2):145-147. 被引量:36
  • 10Kaufmann BA,Lindner JR.Molecular imaging with targeted contrast ultrasound.Curr Opin Biotechnol,2007,18:1t-16.

二级参考文献10

  • 1孟刚,张洪福,饶慧蓉,龚西.乳腺癌组织内微血管分布的定量研究[J].临床与实验病理学杂志,1995,11(1):17-19. 被引量:15
  • 2Weidner N, Folkman J, Pozza F, et al. Tumor angiogenesis: a new significent and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst, 1992, 84:1875-1887.
  • 3Augustin HG. Angiogenic tumor therapy: will it work? Trends Pharmacol Sci, 1998, 19:216-222.
  • 4Gospodarowicz D, Ferrara N, Schweigerer L, et al. Structural characterization and biological functions of fibroblast growth factor.Endocr Rev,1987, 8:95-114.
  • 5Van der Zee R, Murohara T, Lao Z, et al. Vascular endothelial growth factor/vascular permeability factor augments nitric oxide release from quiescent rabbit and human vascular endothelium. Circulation, 1997,95 : 1030-1037.
  • 6Toi M, Hoshina S, Takayanagi T, et al. Association of vascular endothelial growth factor expression with tumor angiogenesis and with early relapse in primary breast cancer. Jpn J Cancer Res, 1994, 85:1045-1049.
  • 7Bosari S, Lee AK, DeLellis RA, et al. Microvessel quantitation and prognosis in invasive breast carcinoma. Hum Pathol, 1992,23:755-761.
  • 8Van Hoef ME, Knox WF, Dhesi SS, et al. Assessment of tumour vascularity as a prognostic fator in lymph node negative invasive breast cancer. Eur J Cancer, 1993,29A:1141-1145.
  • 9Medri L, Nanni O, Volpi A, et al. Tumor microvessel density and prognosis in node-negative breast cancer. Int J Cancer, 2000,89:74-80.
  • 10尹芳,乔泰东,时永全,肖冰,陈宝军,苗继延,樊代明.紧密连接分子Occludin mRNA在胃癌中的表达和分布[J].中华肿瘤杂志,2002,24(6):557-560. 被引量:19

共引文献73

同被引文献30

  • 1王兴华,于晓玲,董宝玮.超声介导超声造影剂在分子影像与基因治疗领域中的应用[J].中华超声影像学杂志,2004,13(11):865-867. 被引量:13
  • 2许幼峰,郭旻华,舒静,王爱玉,陈立斌.超声造影在卵巢肿瘤诊断中的初步应用[J].中国超声医学杂志,2007,23(7):534-537. 被引量:12
  • 3郑磊,田新桥.超声造影剂在心脏疾病诊治中的应用进展[J/CD].中华临床医师杂志:电子版,2013,7(18):8408-8411.
  • 4D'Arcy TJ, Jayaram V, Lynch M, et al. Ovarian cancer detected non-invasively by contrast-enhanced power Doppler ultrasound [J]. B JOG, 2004, 111(6): 619-622.
  • 5Obeidat F, Mismar A, Shomaf M, et al. Gastric perforation secondary to metastasis from ovarian cancer: Case report [J]. Int J Surg Case Rep, 2013, 4(6): 541-543.
  • 6Fleischer AC, Lyshchik A, Jones HW 3rd, et al. Diagnostic parameters to differentiate benign from malignant ovarian masses with contrast-enhanced transvaginal sonography [J]. J Ultrasound Med, 2009, 28(10): 1273-1280.
  • 7Orden MR, Jurvelin JS, Kirkinen PP. Kinetics of a US contrast agent in benign and malignant adnexal tumors [J]. Radiology, 2003, 226(2): 405-410.
  • 8Anderson CR, Rychak J J, Backer M, et al. scVEGF microbubble ultrasound contrast agents: a novel probe for ultrasound molecular imaging of tumor angiogenesis [J]. Invest Radiol, 2010, 45(10): 579-585.
  • 9Anderson CR, Hu X, Zhang H, et al. Ultrasound molecular imaging of tumor angiogenesis with an integrin targeted microbubble contrast agent [J]. Invest Radiol, 2011, 46(4): 215-224.
  • 10Zhou S, Li S, Liu Z, et al. Ultrasound-targeted microbubble destruction mediated herpes simplex virus-thymidine kinase gene treats hepatoma in mice [J]. J Exp Clin Cancer Res, 2010, 29: 170.

引证文献4

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部